Filing Details
- Accession Number:
- 0001127602-20-023257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-10 16:25:13
- Reporting Period:
- 2020-07-16
- Accepted Time:
- 2020-08-10 16:25:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-16 | 2,000 | $0.00 | 239,377 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2020-08-06 | 4,600 | $0.00 | 234,777 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2020-08-07 | 4,713 | $216.34 | 230,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-07 | 19,287 | $217.77 | 210,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,800 | Indirect | 2018 GRAT |
| Common Stock | 25,000 | Indirect | 2019 GRAT |
| Common Stock | 20,000 | Indirect | 2020 GRAT |
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 750 | Indirect | By Trust |
| Common Stock | 2,250 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $216.31 to $216.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $217.66 to $218.275. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
